Financial Statements

Abiomed, Inc. (ABMD)

$266.34

+5.37 (+2.06%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 2021 2020 2019 2018
Retained Earnings (Previous Year) 828602399140-
Net Income 137226203259112
Stock Dividends ----28
Dividend Paid -----
Retained Earnings 965828602399140

PPE Schedule

Year 2022 2021 2020 2019 2018
Gross PPE 203165145117-
Annual Depreciation 35926472173
Capital Expenditure -36-53-44-44-56
Net PPE 202203165145117

Intangible and Goodwill Schedule

Year 2022 2021 2020 2019 2018
Intangible and Goodwill (Previous Year) -36333279
New Purchases -332-404-632-582-806
Intangible and Goodwill 3633327977

Abiomed, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abiomed, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.